102 related articles for article (PubMed ID: 12611459)
1. Mutagen sensitivity of human lymphoblastoid cells with a BRCA1 mutation.
Trenz K; Landgraf J; Speit G
Breast Cancer Res Treat; 2003 Mar; 78(1):69-79. PubMed ID: 12611459
[TBL] [Abstract][Full Text] [Related]
2. Mutagen sensitivity of human lymphoblastoid cells with a BRCA1 mutation in comparison to ataxia telangiectasia heterozygote cells.
Speit G; Trenz K; Schütz P; Bendix R; Dörk T
Cytogenet Cell Genet; 2000; 91(1-4):261-6. PubMed ID: 11173867
[TBL] [Abstract][Full Text] [Related]
3. Radiosensitivity of lymphoblastoid cell lines with a heterozygous BRCA1 mutation is not detected by the comet assay and pulsed field gel electrophoresis.
Trenz K; Schütz P; Speit G
Mutagenesis; 2005 Mar; 20(2):131-7. PubMed ID: 15784691
[TBL] [Abstract][Full Text] [Related]
4. Mutagen sensitivity of peripheral blood from women carrying a BRCA1 or BRCA2 mutation.
Trenz K; Rothfuss A; Schütz P; Speit G
Mutat Res; 2002 Mar; 500(1-2):89-96. PubMed ID: 11890937
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal mutagen sensitivity associated with mutations in BRCA genes.
Speit G; Trenz K
Cytogenet Genome Res; 2004; 104(1-4):325-32. PubMed ID: 15162060
[TBL] [Abstract][Full Text] [Related]
6. Enhanced sensitivity of peripheral blood lymphocytes from women carrying a BRCA1 mutation towards the mutagenic effects of various cytostatics.
Trenz K; Lugowski S; Jahrsdörfer U; Jainta S; Vogel W; Speit G
Mutat Res; 2003 Nov; 544(2-3):279-88. PubMed ID: 14644329
[TBL] [Abstract][Full Text] [Related]
7. Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families.
Rothfuss A; Schütz P; Bochum S; Volm T; Eberhardt E; Kreienberg R; Vogel W; Speit G
Cancer Res; 2000 Jan; 60(2):390-4. PubMed ID: 10667592
[TBL] [Abstract][Full Text] [Related]
8. Primary fibroblasts from BRCA1 heterozygotes display an abnormal G1/S cell cycle checkpoint following UVA irradiation but show normal levels of micronuclei following oxidative stress or mitomycin C treatment.
Shorrocks J; Tobi SE; Latham H; Peacock JH; Eeles R; Eccles D; McMillan TJ
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):470-8. PubMed ID: 14751517
[TBL] [Abstract][Full Text] [Related]
9. DNA repair capacity correlates with mutagen sensitivity in lymphoblastoid cell lines.
Wei Q; Spitz MR; Gu J; Cheng L; Xu X; Strom SS; Kripke ML; Hsu TC
Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):199-204. PubMed ID: 8833620
[TBL] [Abstract][Full Text] [Related]
10. Ionizing radiation or mitomycin-induced micronuclei in lymphocytes of BRCA1 or BRCA2 mutation carriers.
Gutiérrez-Enríquez S; Ramón Y Cajal T; Alonso C; Corral A; Carrasco P; Cornet M; Sanz J; Ribas M; Baiget M; Diez O
Breast Cancer Res Treat; 2011 Jun; 127(3):611-22. PubMed ID: 20625817
[TBL] [Abstract][Full Text] [Related]
11. Prediction of BRCA1 and BRCA2 mutation status using post-irradiation assays of lymphoblastoid cell lines is compromised by inter-cell-line phenotypic variability.
Lovelock PK; Wong EM; Sprung CN; Marsh A; Hobson K; French JD; Southey M; Sculley T; Pandeya N; Brown MA; Chenevix-Trench G; Spurdle AB; McKay MJ;
Breast Cancer Res Treat; 2007 Sep; 104(3):257-66. PubMed ID: 17063265
[TBL] [Abstract][Full Text] [Related]
12. Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2.
Buchholz TA; Wu X; Hussain A; Tucker SL; Mills GB; Haffty B; Bergh S; Story M; Geara FB; Brock WA
Int J Cancer; 2002 Feb; 97(5):557-61. PubMed ID: 11807777
[TBL] [Abstract][Full Text] [Related]
13. Lymphocytes of BRCA1 and BRCA2 germ-line mutation carriers, with or without breast cancer, are not abnormally sensitive to the chromosome damaging effect of moderate folate deficiency.
Beetstra S; Salisbury C; Turner J; Altree M; McKinnon R; Suthers G; Fenech M
Carcinogenesis; 2006 Mar; 27(3):517-24. PubMed ID: 16162645
[TBL] [Abstract][Full Text] [Related]
14. Unsuitability of lymphoblastoid cell lines as surrogate of cryopreserved isolated lymphocytes for the analysis of DNA double-strand break repair activity.
Zijno A; Porcedda P; Saini F; Allione A; Garofalo B; Marcon F; Guarrera S; Turinetto V; Minieri V; Funaro A; Crebelli R; Giachino C; Matullo G
Mutat Res; 2010 Feb; 684(1-2):98-105. PubMed ID: 20035771
[TBL] [Abstract][Full Text] [Related]
15. Gene-modified spontaneous Epstein-Barr virus-transformed lymphoblastoid cell lines as autologous cancer vaccines: mutated p21 ras oncogene as a model.
Kubuschok B; Cochlovius C; Jung W; Schmits R; Trümper L; Hartmann F; Renner C; Pfreundschuh M
Cancer Gene Ther; 2000 Sep; 7(9):1231-40. PubMed ID: 11023195
[TBL] [Abstract][Full Text] [Related]
16. Induction of micronuclei in human cell lines and primary cells by combination treatment with gamma-radiation and ethyl methanesulfonate.
Stopper H; Lutz WK
Mutagenesis; 2002 Mar; 17(2):177-81. PubMed ID: 11880548
[TBL] [Abstract][Full Text] [Related]
17. Insensitivity of the in vitro cytokinesis-block micronucleus assay with human lymphocytes for the detection of DNA damage present at the start of the cell culture.
Speit G; Linsenmeyer R; Schütz P; Kuehner S
Mutagenesis; 2012 Nov; 27(6):743-7. PubMed ID: 22869611
[TBL] [Abstract][Full Text] [Related]
18. The principal phenolic and alcoholic components of wine protect human lymphocytes against hydrogen peroxide- and ionizing radiation-induced DNA damage in vitro.
Greenrod W; Fenech M
Mutagenesis; 2003 Mar; 18(2):119-26. PubMed ID: 12621066
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 and BRCA2 heterozygosity and repair of X-ray-induced DNA damage.
Nieuwenhuis B; Van Assen-Bolt AJ; Van Waarde-Verhagen MA; Sijmons RH; Van der Hout AH; Bauch T; Streffer C; Kampinga HH
Int J Radiat Biol; 2002 Apr; 78(4):285-95. PubMed ID: 12020440
[TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of a breast cell strain containing a BRCA1 185delAG mutation.
Annab LA; Terry L; Cable PL; Brady J; Stampfer MR; Barrett JC; Afshari CA
Gynecol Oncol; 2000 Apr; 77(1):121-8. PubMed ID: 10739701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
